Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?

BACKGROUND: Tetrabenazine is the only US Food and Drug Administration‐approved drug for Huntington's disease, and deutetrabenazine was recently tested against placebo. A switching‐trial from tetrabenazine to deutetrabenazine is underway, but no head‐to‐head, blinded, randomized controlled trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, Filipe B., Duarte, Gonçalo S., Costa, João, Ferreira, Joaquim J., Wild, Edward J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573977/
https://www.ncbi.nlm.nih.gov/pubmed/28920068
http://dx.doi.org/10.1002/mdc3.12483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573977/
https://www.ncbi.nlm.nih.gov/pubmed/28920068
http://dx.doi.org/10.1002/mdc3.12483

Ejemplares similares